Prospective phase II study of: neo-adjuvant doxorubicin followed sequentially by cisplatin/docetaxel in locally advanced breast cancer

Locally Advanced ◽

Advanced Breast ◽

Prospective Phase

Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer

Medical Oncology ◽

10.1007/s12032-009-9251-7 ◽

2009 ◽

Vol 27 (3) ◽

pp. 571-577 ◽

Cited By ~ 6

Author(s):

Taher A. Al-Tweigeri ◽

Dahish S. Ajarim ◽

Adher A. Alsayed ◽

Mohamed M. Rahal ◽

Mohamed O. Alshabanah ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Breast ◽

Prospective Phase

225P Phase II study of pyrotinib plus albumin-bound paclitaxel and trastuzumab as neoadjuvant treatment in HER2-positive early or locally advanced breast cancer

Annals of Oncology ◽

10.1016/j.annonc.2020.08.346 ◽

2020 ◽

Vol 31 ◽

pp. S331

Author(s):

T. Luo ◽

X. Zhong ◽

P. He ◽

X. Yan ◽

T. Tian ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Neoadjuvant Treatment ◽

Advanced Breast ◽

Her2 Positive

Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study

Oncotarget ◽

10.18632/oncotarget.17954 ◽

2017 ◽

Vol 8 (45) ◽

pp. 79305-79314 ◽

Cited By ~ 12

Author(s):

Liheng Zhou ◽

Shuguang Xu ◽

Wenjin Yin ◽

Yanpin Lin ◽

Yueyao Du ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel

Phase II study of neoadjuvant gemcitabine, epirubicin, and albumin-bound nab paclitaxel (GEA) in locally advanced breast cancer with SPARC tumor assessments

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.603 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 603-603 ◽

Cited By ~ 2

Author(s):

D. A. Yardley ◽

R. C. Inhorn ◽

D. Daniel ◽

B. Daniel ◽

Y. Naot ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Epirubicin and Docetaxel as Neoadjuvant Treatment of Locally Advanced Breast Cancer: A Phase II Study

Tumori Journal ◽

10.1177/030089161009600207 ◽

2010 ◽

Vol 96 (2) ◽

pp. 229-233 ◽

Cited By ~ 2

Author(s):

Davide Lombardi ◽

Simona Scalone ◽

Diana Crivellari ◽

Maria Donatella Magri ◽

Nicoletta La Mura ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Neoadjuvant Treatment ◽

Neoadjuvant use of 5-fluorouracil, epirubicin and cyclophosphamide with and without celecoxib for locally advanced breast cancer: A phase II study correlating response to celecoxib with high levels of COX-2 gene expression in the tumor

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.9603 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 9603-9603

Author(s):

L. W. Chow ◽

M. Toi ◽

Y. Takebayashi

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Breast ◽

Cox 2

Phase II study of neoadjuvant gemcitabine (GC), pegylated liposomal doxorubicin (DX) and docetaxel (TT) in locally advanced breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.606 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 606-606

Author(s):

G. Cartei ◽

L. Borgato ◽

G. Lombardi ◽

A. Cappetta ◽

F. Bozza ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Locally Advanced ◽

Pegylated Liposomal Doxorubicin ◽

Abstract P1-11-08: A Multicenter Prospective Phase II Trial of Neo-Adjuvant (FEC 100)/Cisplatin-Docetaxel with or without Trastuzumab in Locally Advanced Breast Cancer. Gulf Oncology Research Group (G0RG-001)

10.1158/0008-5472.sabcs10-p1-11-08 ◽

2010 ◽

Author(s):

TA AL-Tweigeri ◽

AA Alsayed ◽

MM Ibrahim ◽

WM Ashaur ◽

HN Jaafar ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

Oncology Research ◽

Prospective Phase

Safety and feasibility of biweekly neoadjuvant gemcitabine, epirubicin, and albumin bound nab-paclitaxel (GEA) in locally advanced breast cancer – results of a phase II study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(08)70557-3 ◽

2008 ◽

Vol 6 (7) ◽

pp. 119-120

Author(s):

D. Daniel ◽

B. Daniel ◽

R. Inhorn ◽

Y. Naot ◽

J. Zubkus ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study

Breast Cancer Research and Treatment ◽

10.1007/s10549-014-3221-2 ◽

2014 ◽

Vol 149 (1) ◽

pp. 163-169 ◽

Cited By ~ 8

Author(s):

A. R. Tan ◽

H. Johannes ◽

P. Rastogi ◽

S. A. Jacobs ◽

A. Robidoux ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Neoadjuvant Therapy ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel